John Brendan Doyle - 15 Feb 2026 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Chief Financial Officer
Signature
/s/ John Brendan Doyle
Issuer symbol
CGTX
Transactions as of
15 Feb 2026
Net transactions value
-$1,747
Form type
4
Filing time
18 Feb 2026, 16:16:26 UTC
Previous filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle John Brendan Chief Financial Officer C/O COGNITION THERAPEUTICS INC, 2500 WESTCHESTER AVE., PURCHASE /s/ John Brendan Doyle 18 Feb 2026 0001840738

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Tax liability $1,747 -1,560 -0.25% $1.12 617,509 15 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.